Literature DB >> 27050906

mTOR transcriptionally and post-transcriptionally regulates Npm1 gene expression to contribute to enhanced proliferation in cells with Pten inactivation.

Rafik Boudra1,2,3, Rosyne Lagrafeuille1,2,3, Corinne Lours-Calet1,2,3, Cyrille de Joussineau1,2,3, Gaëlle Loubeau-Legros1,2,3, Cédric Chaveroux4, Jean-Paul Saru1,2,3, Silvère Baron1,2,3, Laurent Morel1,2,3, Claude Beaudoin1,2,3.   

Abstract

The mammalian target of rapamycin (mTOR) plays essential roles in the regulation of growth-related processes such as protein synthesis, cell sizing and metabolism in both normal and pathological growing conditions. These functions of mTOR are thought to be largely a consequence of its cytoplasmic activity in regulating translation rate, but accumulating data highlight supplementary role(s) for this serine/threonine kinase within the nucleus. Indeed, the nuclear activities of mTOR are currently associated with the control of protein biosynthetic capacity through its ability to regulate the expression of gene products involved in the control of ribosomal biogenesis and proliferation. Using primary murine embryo fibroblasts (MEFs), we observed that cells with overactive mTOR signaling displayed higher abundance for the growth-associated Npm1 protein, in what represents a novel mechanism of Npm1 gene regulation. We show that Npm1 gene expression is dependent on mTOR as demonstrated by treatment of wild-type and Pten inactivated MEFs cultured with rapamycin or by transient transfections of small interfering RNA directed against mTOR. In accordance, the mTOR kinase localizes to the Npm1 promoter gene in vivo and it enhances the activity of a human NPM1-luciferase reporter gene providing an opportunity for direct control. Interestingly, rapamycin did not dislodge mTOR from the Npm1 promoter but rather strongly destabilized the Npm1 transcript by increasing its turnover. Using a prostate-specific Pten-deleted mouse model of cancer, Npm1 mRNA levels were found up-regulated and sensitive to rapamycin. Finally, we also showed that Npm1 is required to promote mTOR-dependent cell proliferation. We therefore proposed a model whereby mTOR is closely involved in the transcriptional and posttranscriptional regulation of Npm1 gene expression with implications in development and diseases including cancer.

Entities:  

Keywords:  Npm1; cell proliferation; gene expression; mTOR; prostate cancer

Mesh:

Substances:

Year:  2016        PMID: 27050906      PMCID: PMC4889308          DOI: 10.1080/15384101.2016.1166319

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  48 in total

1.  Preferential cleavage in pre-ribosomal RNA byprotein B23 endoribonuclease.

Authors:  R S Savkur; M O Olson
Journal:  Nucleic Acids Res       Date:  1998-10-01       Impact factor: 16.971

2.  Role of nucleophosmin in embryonic development and tumorigenesis.

Authors:  Silvia Grisendi; Rosa Bernardi; Marco Rossi; Ke Cheng; Luipa Khandker; Katia Manova; Pier Paolo Pandolfi
Journal:  Nature       Date:  2005-07-06       Impact factor: 49.962

3.  The target of rapamycin signaling pathway regulates mRNA turnover in the yeast Saccharomyces cerevisiae.

Authors:  A R Albig; C J Decker
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

4.  Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23.

Authors:  E N Subong; M J Shue; J I Epstein; J V Briggman; P K Chan; A W Partin
Journal:  Prostate       Date:  1999-06-01       Impact factor: 4.104

5.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

6.  Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model.

Authors:  Pradip K Majumder; Jen Jen Yeh; Daniel J George; Phillip G Febbo; Jennifer Kum; Qi Xue; Rachel Bikoff; Hongfeng Ma; Philip W Kantoff; Todd R Golub; Massimo Loda; William R Sellers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-10       Impact factor: 11.205

7.  Hypoxia-induced nucleophosmin protects cell death through inhibition of p53.

Authors:  June Li; Xiaoling Zhang; Daniel P Sejas; Grover C Bagby; Qishen Pang
Journal:  J Biol Chem       Date:  2004-08-13       Impact factor: 5.157

8.  Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

Authors:  Shunyou Wang; Jing Gao; Qunying Lei; Nora Rozengurt; Colin Pritchard; Jing Jiao; George V Thomas; Gang Li; Pradip Roy-Burman; Peter S Nelson; Xin Liu; Hong Wu
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

9.  mTOR signaling regulates the processing of pre-rRNA in human cells.

Authors:  Valentina Iadevaia; Ze Zhang; Eric Jan; Christopher G Proud
Journal:  Nucleic Acids Res       Date:  2011-11-24       Impact factor: 16.971

10.  Destabilization of nucleophosmin mRNA by the HuR/KSRP complex is required for muscle fibre formation.

Authors:  Anne Cammas; Brenda Janice Sanchez; Xian Jin Lian; Virginie Dormoy-Raclet; Kate van der Giessen; Isabel López de Silanes; Jennifer Ma; Carol Wilusz; John Richardson; Myriam Gorospe; Stefania Millevoi; Matteo Giovarelli; Roberto Gherzi; Sergio Di Marco; Imed-Eddine Gallouzi
Journal:  Nat Commun       Date:  2014-06-27       Impact factor: 14.919

View more
  3 in total

1.  Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.

Authors:  Zsofia Turi; Marketa Senkyrikova; Martin Mistrik; Jiri Bartek; Pavel Moudry
Journal:  Cell Cycle       Date:  2017-12-10       Impact factor: 4.534

2.  O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.

Authors:  Anna Barkovskaya; Kotryna Seip; Bylgja Hilmarsdottir; Gunhild M Maelandsmo; Siver A Moestue; Harri M Itkonen
Journal:  Sci Rep       Date:  2019-04-05       Impact factor: 4.379

3.  Microarray analysis and functional prediction of differentially expressed circular RNAs in acquired middle ear cholesteatoma.

Authors:  Shumin Xie; Li Jin; Tuanfang Yin; Jihao Ren; Wei Liu
Journal:  Biomed Eng Online       Date:  2021-12-18       Impact factor: 2.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.